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Background
The tumour suppressor protein p53 plays a major role in
modulating cellular functions such as DNA repair, cell
cycle arrest and apoptosis. Mutation in the p53 gene is
known to be one of the most frequently observed genetic
alterations during tumorigenesis. Under normal cellular
condition, the p53 protein is kept at very low levels in a
'stand-by' mode. In response to cellular stresses like
hypoxia or nucleotide depletion, p53 is activated and
binds to promoter elements (p53 response elements)
within its downstream target genes, and regulates their
transcriptions initiating the cellular activities that account
for most of its tumour suppressor function. The p53
response element (p53 RE) consists of two repeated cop-
ies of 5'-PuPuPuC(A/T)(A/T)GPyPyPy-3' with a spacer of
up to 13 bp in between. By identifying genes regulated by
p53, we hope to achieve a better understanding of their
interactions with p53 in maintaining cellular integrity.
Many studies have been carried out on p53 binding sites
and in developing different algorithms to identify p53 RE
in human genomes. However, the prediction of p53 target
genes based on only p53 RE alone might be insufficient.
Thus, we have further investigated if additional elements
adjacent to the p53 binding site may also have a role in
modulating p53 binding in these target genes.
Results
The performance of the program was tested using the
sequences of a group of p53 downstream target genes
gathered from the literature as positive control genes. It
was capable of detecting the p53 response elements in all
the control genes. In addition, the consensus motifs adja-
cent to the p53 response elements were also detected in
majority of them. As for the negative control genes, only
one gene was predicted to be a weak p53 target gene.
Conclusion
The program is capable of identifying the p53 response
elements in the potential p53 target genes, by having
selectivity of 76% to pick up the real p53 target genes and
sensitivity of 97% to reject the non p53 target genes. It has
also proven that the consensus motifs adjacent to the p53
RE are presence in these p53 target genes. Hence, we
believe that these additional elements adjacent to p53 RE
may play a role in facilitating the p53 binding to its
response element.
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